Compound information
- Natural Products
- ZC2032274
- Molecular Formula
- C23H27ClN4O3
- Molecular Weight
- 442.177168404 g/mol
- Structure
-
- IUPAC Name
- 4-[[(2S)-2-acetamido-3-phenyl-propanoyl]amino]-N-(4-chlorophenyl)piperidine-1-carboxamide
- InChI
- InChI=1S/C23H27ClN4O3/c1-16(29)25-21(15-17-5-3-2-4-6-17)22(30)26-20-11-13-28(14-12-20)23(31)27-19-9-7-18(24)8-10-19/h2-10,20-21H,11-15H2,1H3,(H,25,29)(H,26,30)(H,27,31)/t21-/m0/s1
- InChI Key
- LBESEVVAKKRUCN-NRFANRHFSA-N
- SMILES
- CC(=O)N[C@@H](Cc1ccccc1)C(=O)NC1CCN(C(=O)Nc2ccc(Cl)cc2)CC1
- Source
- ZINC000013084884
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 90.54 Å2 | LogP | 2.825 |
LogS | -4.082 | LogD | 2.79 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.789 | Pgp substrate | 0.962 |
HIA | 0.281 | F20 % | 0.942 |
F30 % | 0.025 | Caco-2 | -5.31 |
MDCK | -5.478 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.064 | PPB | 93.924 |
VD | 0.683 | Fu | 1.307 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.005 | CYP1A2 substrate | 0.63 |
CYP2A6 substrate | 0.576 | CYP2B6 substrate | 0.542 |
CYP2C19 inhibitor | 0.669 | CYP2C19 substrate | 0.899 |
CYP2C8 substrate | 0.859 | CYP2C9 inhibitor | 0.055 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.929 | CYP2E1 substrate | 0.442 |
CYP3A4 inhibitor | 0.032 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.304 | CL | 2.349 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.238 | Hepatotoxicity | 0.848 |
Mutagenicity | 0.005 | Rat Oral Acute Toxicity | 0.405 |
FDAMDD | 0.392 | Skin Sensitization | 0.092 |
Carcinogenicity | 0.012 | Eye Corrosion | 0.009 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.045 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.518 | IGC50 | 2.858 |
LC50FM | -8.195 | LC50DM | -0.579 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.289 | NR-AR-LBD | 0.255 |
NR-AhR | 0.213 | NR-Aromatase | 0.033 |
NR-ER | 0.389 | NR-ER-LBD | 0.331 |
NR-PPAR-gamma | 0.386 | SR-ARE | 0.605 |
SR-ATAD5 | 0.448 | SR-HSE | 0.187 |
SR-MMP | 0.107 | SR-p53 | 0.18 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.